Holte, Denmark

Steven B Levery


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:

goldMedal1 out of 832,680 
Other
 patents

Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Glyco-Engineering by Steven B Levery

Introduction

Steven B Levery is an accomplished inventor based in Holte, Denmark. He has made significant contributions to the field of glyco-engineering, particularly in the development of plant-based systems for producing bioactive glycoproteins and cancer-specific vaccines. His innovative approach leverages the unique properties of plant cells to facilitate human O-glycosylation, a process traditionally reliant on mammalian cells.

Latest Patents

Levery holds a patent for "Methods for glyco-engineering plant cells for controlled human O-glycosylation." This invention outlines a novel platform for the recombinant production of glycoproteins and cancer vaccines in plants. The technology enables the humanization of plant cell cultures concerning human mucin-type protein O-glycosylation. The platform allows for the production of a wide array of O-glycosylated human glycoprotein therapeutics, including improved cancer vaccine candidates.

Career Highlights

Throughout his career, Levery has focused on the engineering of plant cells to produce therapeutically valuable glycoproteins. His work has established a foundation for the production of human glycoproteins that can be utilized in various medical applications. By introducing specific enzymes and substrates into plant cells, he has successfully demonstrated the potential for these cells to perform human-type O-glycosylation.

Collaborations

Levery has collaborated with notable colleagues, including Zhang Yang and Damian Paul Drew. These partnerships have further advanced the research and development of glyco-engineering techniques, enhancing the potential applications of his inventions.

Conclusion

Steven B Levery's innovative work in glyco-engineering represents a significant advancement in the field of biotechnology. His patented methods for utilizing plant cells for human O-glycosylation open new avenues for therapeutic development. The impact of his research is poised to benefit the medical community and improve treatment options for various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…